Biopharmaceutical Manufacturing, Upstream, Downstream …
Symbiosis expands sterile manufacturing with new facility and innovations. Quotient Sciences expands with mRNA Focus at CPHI 2024. CBD-based formulations from dsm-firmenich at CPHI 2024. News on the biopharmaceutical manufacturing industry, focusing on biologics, technology, upstream/downstream processing, cell culture and regulations.
GE Healthcare Life Sciences completes transition into Cytiva
Apr 1, 2020 · Now, with the deal complete, GE Healthcare Life Sciences has emerged at the other side rebranded as Cytiva. The company will retain the same staff, which means that it will have 7,000 employees and possess operations in 40 countries, becoming part of Danaher Corporation Life Sciences platform. CEO and president of Cytiva, Emmanuel Ligner, spoke ...
COVID-19: Meissner secures $13.4m BARDA award to produce …
May 3, 2021 · Meissner Filtration Products has just been awarded a US$13.4m contract from the US government agency, BARDA, to boost its production capability for components critical to vaccines and therapies linked to the COVID-19 response. The company, which manufactures advanced microfiltration products and single-use systems for critical pharmaceutical ...
CytoImmune Therapeutics opens clinical cell manufacturing facility …
Mar 28, 2022 · CytoImmune Therapeutics, a clinical-stage immunotherapy company developing a novel class of engineered natural killer (NK) cell-based cancer therapies, has announced the opening of its clinical cell manufacturing facility in Toa Baja, Puerto Rico. The California-headquartered company says the early investment in manufacturing capabilities will ...
Pharma and biopharma outsourcing strategies need to use an …
Oct 26, 2022 · But a new CPhI report on 'The Future of Outsourcing' advises against this approach. “Traditionally, outsourcing strategies were designed to help secure next stage funding, but many biotechs and small pharma companies are now entering development with more robust cash flows and the ability to plan further downstream," "This opens the door for ...
Fujifilm to invest $1.6bn and make its Hillerød facility in Denmark …
Jun 30, 2022 · Almost all of the investment will be ploughed into FDB's site in Hillerød, Denmark, which Fujifilm acquired from Biogen in August 2019.. Some 450 jobs will be created at the Danish campus, to add to the 1,055 employees currently on-site, said the company.
MeiraGTx unveils Ireland’s first commercial-scale gene therapy ...
Sep 19, 2022 · MeiraGTx has formally opened its new GMP gene therapy manufacturing operations in Shannon, Ireland. Operational since earlier this year and stretching over 150,000 sq. ft (13935.4 sq. m), it is the first commercial-scale gene therapy manufacturing site in Ireland. The newly developed complex comprises three facilities, one built to be flexible ...
AstraZeneca starts new chapter as Alexion acquisition closes
Jul 21, 2021 · AstraZeneca heralds new chapter as Alexion acquisition completed. AstraZeneca has completed the acquisition of Alexion Pharmaceuticals, Inc., marking its entry into medicines for rare diseases. The $39bn deal, announced in December 2020, is AstraZeneca’s largest ever acquisition: allowing it to move further into immunology with an enhanced ...
Glenmark launches Ichnos Sciences - biopharma-reporter.com
Oct 17, 2019 · Glenmark launches Ichnos Sciences. News and analysis on the clinical development and manufacture of large molecule drugs. Glenmark spins out bispecific portfolio through Ichnos. Ichnos will launch with a portfolio of five clinical stage assets, a proprietary platform, as well as a biologics manufacturing facility and 350 employees.
CJ Cheiljedang set to acquire Batavia Biosciences for $226m
Nov 8, 2021 · A leading producer of lysine for animal feed, CJ Cheiljedang said its board backed the proposed acquisition of a 75.8% stake in Netherlands-based Batavia Biosciences for 267.7bn won ($226m or €195.3m), according to Korean media coverage , citing a regulatory filing by the firm.. CJ Cheiljedang said it will purchase 50,807 shares in Batavia including 13,007 new shares, at €3,844 euros per ...